|
|
Clinical observation of acupuncture combined with medicine in the treatment of hypertension with atherosclerosis |
LIANG Hao1,2 YU Ying1 ZHOU Zhongguang1 |
1.Research Institute of Traditional Chinese Medicine, Heilongjiang University of Traditional Chinese Medicine, Heilongjiang Province, Harbin 150001, China; 2.Department of Acupuncture and Moxibustion, Heilongjiang Academy of Sciences of Traditional Chinese Medicine, Heilongjiang Province, Harbin 150036, China |
|
|
Abstract Objective To observe the clinical effect of Yangmai Huatan Decoction combined with acupuncture in the treatment of hypertension with atherosclerosis. Methods From June 2017 to September 2018, 100 cases of vertigo patients were selected from the outpatient department and ward of Department of Acupuncture and Moxibustion, Heilongjiang Academy of Sciences of Traditional Chinese Medicine. The patients were divided into combined treatment group and control group, each group with 50 cases. The final effective cases were 84 cases, 43 cases in combined treatment group and 41 cases in control group. The patients in control group were treated with Western medicine standardized antihypertensive, antiplatelet, hypolipidemic and other symptomatic treatment. On this basis, the patients in combined treatment group were treated with Yangmai Huatan Decoction and acupuncture. Patients of two groups were treated continuously for two months. Before and after treatment, blood pressure, arterial media thickness (IMT), resistance index (RI), serum anti oxidant and inflammatory factors were observed in two groups. Results The levels of systolic and diastolic blood pressure in two groups were lower than those before treatment, the difference was statistically significant (P < 0.05). IMT of bilateral common carotid artery in two groups after treatment was thinner than that before treatment, and the change in combined treatment group was more significant than that in control group, the difference was statistically significant (P < 0.05). RI of bilateral renal arteries in two groups after treatment was lower than that before treatment, and the change in combined treatment group was more significant than that in control group, the difference was statistically significant (P < 0.05). Levels of superoxide dismutase and malondialdehyde in two groups after treatment were higher than those before treatment, the levels of tumer necrosis faltor-α and interleukin-6 were lower than those before treatment, and the changes in combined treatment group were more significant than those in control group, the difference was statistically significant (P < 0.05). Conclusion The combination of acupuncture and medicine can effectively delay the progression of atherosclerosis in patients with hypertension, which is significantly better than western medicine alone in reducing blood pressure, lipid and antiplatelet therapy. This therapeutic effect is independent of the decrease of blood pressure, and may play a therapeutic effect by inhibiting the inflammatory response and oxidative stress injury in patients.
|
|
|
|
|
[1] GBD 2013 Mortality and Causes of Death Collaborators. Global,regional,and national age-sex specific all-cause and cause-specific mortality for 240 causes of death,1990-2013:a systematic analysis for the Global Burden of Disease Study 2013 [J]. Lancet,2015,385:117-171.
[2] 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011,39(7):579-616.
[3] 王陇德.中国居民营养与健康状况调查报告之一2002综合报告[M].北京:人民卫生出版社,2005.
[4] 杜德炜.温针灸结合颞三针治疗中风后肢体功能障碍的临床研究[D].广州:广州中医药大学,2015.
[5] 张新颖.腹针结合阿托伐他汀钙治疗颈动脉粥样硬化的临床研究[D].新乡:新乡医学院,2016.
[6] 张雪婷.针剌左侠溪穴对椎—基底动脉系统的TIA患者大脑后动脉血流动力学的影响[D].哈尔滨:黑龙江中医药大学,2015.
[7] 胡楠,于睿,张威,等.眼针联合疏肝清脂法治疗颈部动脉粥样硬化合并斑块的临床观察[J].辽宁中医杂志,2018, 45(10):2160-2163.
[8] 牛俊娟.针药联合治疗高血压颈动脉粥样硬化的临床观察[J].中国医药指南,2016,14(17):205-206.
[9] 冯丽丽.脉管通胶囊联合西药治疗动脉粥样硬化斑块60例临床观察[J].中国民族民间医药,2018,27(14):81-84.
[10] 秦卫,王芳,王梅,等.彩色多普勒超声在动脉粥样硬化性肾动脉狭窄诊断中的应用[J].中华超声影像学杂志,2005,14(7):508-511.
[11] 刘少鸿,袁小霞.穴位推拿联合益气定眩汤治疗颈性眩晕的临床研究[J].中医药导报,2019,25(3):111-114.
[12] Chen Y,Waqar AB,Yan H,et al. Renovascular hypertension aggravates atherosclerosis in cholesterol-fed rabbits [J]. J Vasc Res,2019,56(1):28-38.
[13] Huo KG,Richer C,Berillo O,et al. miR-431-5p knockdown protects against angiotensin Ⅱ-induced hypertension and vascular injury [J]. Hypertension,2019,73(5):1007-1017.
[14] 黄侠.内皮细胞微颗粒和动脉粥样硬化及冠心病的研究进展[J].中国医师杂志,2015,z(1):257-259.
[15] 刘俊田.动脉粥样硬化发病的炎症机制的研究进展[J].西安交通大学学报:医学版,2015,17(2):141-152.
[16] 李乐亮.炎症标志物与颈动脉粥样斑块的稳定性[J].心血管病学进展,2016,37(3):219-224.
[17] 范桢亮.祛瘀化浊汤治疗CKD-Ⅳ期湿浊瘀血证伴血管钙化的临床观察[D].哈尔滨:黑龙江中医药大学,2017.
[18] 徐绥宁.巨噬细胞在动脉粥样硬化消退中作用的研究进展[J].中华心血管病杂志,2016,44(3):278-280.
[19] 于泽谋.血管稳态对动脉粥样硬化发生发展影响的研究进展[J].国际神经病学神经外科学杂志,2016,43(4):346-349.
[20] 牛镜磊.新型炎症标志物在动脉粥样硬化中的研究进展[J].中国循环杂志,2017,32(5):516-517.
[21] 郭鑫.血凝集素样氧化型低密度脂蛋白受体l与动脉粥样硬化性疾病的研究进展[J].中风与神经疾病杂志,2018,35(1):86-90.
[22] 翟纯刚.DKK3抑制动脉粥样硬化病变和心肌纤维化的作用及其机制研究[D].济南:山东大学,2018.
[23] 张强.Ox-LDL在动脉粥样硬化中的致病机制及检测方法研究进展[J].国际检验医学杂志,2018,39(19):2432-2436.
[24] 邓娟娟,杨春霞.温针灸联合人参养荣丸治疗椎基底动脉缺血性眩晕的临床研究[J].中医药导报,2018,24(6):74-76.
[25] 郝俊岭,杨雨民,刘婷,等.呼和浩特市城区男性高血压病调查及中医证型分布[J].中医药导报,2019,25(4):79-81.
[26] 范桢亮,杨乔瑞,于珊珊,等.腺苷信号通路在肾纤维化中调节作用[J].辽宁中医药大学学报,2019,21(3):117-181.
[27] Presta V,Figliuzzi I,Miceli F,et al. Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention:analysis of a large real practice database in Italy [J]. Atherosclerosis,2019,285(8):40-48. |
|
|
|